2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92562°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
À¯Áø¿Â¹ÂÁ÷, ±¹³» ÃÖ´ë »ó±Ý ±Ô¸ð ¾Æ¸¶Ãß¾î ÄáÄí¸£ °³ÃÖ (2024-01-20)
´ëÇÑÇ×°ø, °í¸¶¾²¡¤¾Æ¿À¸ð¸® ¿îÇ× Àç°³ (2023-11-29)
KB±¹¹ÎÀºÇà, °³Àλç¾÷ÀÚ À§ÇÑ ¸ÂÃãÇü Ç÷§Æû '»çÀå´Ô+' ¿ÀÇ (2024-05-26)
Ÿ°ø ÇÊ¿ä ¾ø´Â Ãʰ£Æí ¿¡¹Ù Ŭ¸®³Ê '´ÚÅÍ¿¡¹Ù' Ãâ½Ã (2017-05-24)
¡®°íµù¾öºü4¡¯ ±Ç¿ÀÁß °Ô½ºÆ® Ã⿬... ³²´Ù¸¥ ºÎ¼º¾ÖÀÇ ¾ÆÀÌÄÜ (2024-01-17)
½´ÆÛ³Î, ½ÅÇü UAM ±âüÀÇ Æ¼Àú À̹ÌÁö °ø°³ (2023-12-22)
¡®À§³ª¡¯ ¿øÀÌX¿¬¼­ À¯´Ö, ½Å°î ¡®¹Ù¶÷¡¯ ¹ß¸Å (2023-10-31)
¼ö¼º¾ËÆÄ½ÃƼ ±Ù·ÎÀÚ, ¸ðºí¹ö½º ÀÌ¿ë ¸¸Á·µµ 100% (2023-10-05)
µÈ´Ù µÈ´Ù Ã¥¾²±â°¡ µÈ´Ù (2016-01-07)
Schneider Electric supports Hi! PARIS and its artificial int... (2023-02-10)
LS MnM, 2Â÷ÀüÁö ¼ÒÀç »ç¾÷ º»°Ý ÁøÀÔ (2023-10-28)
¿Ü±â¿Âµµ¿¡ µû¸¥ Àü±âÂ÷ ¹èÅ͸® ¼Ò¸ð Ư¼º ºÐ¼® (2024-04-01)
½¬´Â °Ô º¸¾à¡¦ û¼Ò³â Èú¸µ ÇÁ·Î±×·¥ ¡®½², ½É½Å ½°¡¯ ¿î¿µ (2024-06-18)
Åõ½æÇ÷¹À̽º ¡®¹Ù³ª³ª ¼¦ ¾Æ¸Þ¸®Ä«³ë¡¯ & ¡®¹Ù³ª³ª ¼¦ ¶ó¶¼¡¯ ... (2024-09-30)
Schneider Electric to modernize and automate Serbia¡¯s entir... (2023-07-13)
ü°¨Çü °ÔÀÓ Àü¿ë ¸ÅÀå ¡®Ç÷¹À̽ºÆÌ¡¯ (2017-01-04)
Ãë¾÷Áغñ»ý ¾îÇÐÆò±Õ ÅäÀÍ 682Á¡, Å佺 ·¹º§5 (2016-01-26)
Ä«Å׳ëÀ̵å, ÄÝ·¯½º ¶óÀ̺ê Ä¿¸Ó½º¿¡ ¡®¼ôŬ¸³¡¯ ±â´É Ãâ½Ã (2024-06-15)
·¹µåÆäÀ̽º, ½ºÅ¸ÀÏ¡¤±â´É¼º °®Ãá ¾Æ¿ôµµ¾î üũ ¼ÅÃ÷ Ãâ½Ã (2023-08-05)
Chartered Accountants Australia and New Zealand Rearchitects... (2023-11-17)
UL Solutions Publicly Files Registration Statement for Propo... (2023-11-14)
ÇÒ¸®½ºÄ¿ÇÇ, ½ºÆ½Ä¿ÇÇ & µå¸³¹é Ä¿ÇÇ Ãâ½Ã (2017-09-20)
Visa and Swift Team Up to Enhance Transparency, Speed and Se... (2023-09-20)
½Å±¸´ë VR°ÔÀÓÄÜÅÙÃ÷°ú, ¿¹ºñ Áö¿øÀÚ ´ë»ó °í±³ ¹æ¹® Ư°­ (2023-12-07)
ÇÑÈ­»ý¸í, ¸®Æ÷±×·ì°ú Àεµ³×½Ã¾Æ ¡®³ëºÎÀºÇ࡯ ÁֽĸŸŰè¾à (2024-05-14)
       [ÀÌÀü][1]....[791][792][793][794][795][796][797][798][799]...[3703][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..